ロード中...
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial
OBJECTIVE: To compare patient reported measures of function, health related quality of life (QoL), and satisfaction with medication among patients with rheumatoid arthritis (RA) treated with methotrexate (MTX), etanercept, or both for up to 1 year. METHODS: In a 52 week, double blind, clinical trial...
保存先:
主要な著者: | , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BMJ Group
2006
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1798055/ https://ncbi.nlm.nih.gov/pubmed/16079172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2005.035709 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|